David L. Lacey - Net Worth and Insider Trading

Over the past 18 months, David L. Lacey made no insider transaction in Nurix Therapeutics Inc (NRIX). Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 31,786 shares made by Houte Hans Van , a net sale of 9,451 shares made by Christine Ring , and a net sale of 10,406 shares made by Gwenn Hansen .

In summary, during the past 3 months, insiders sold 10,402 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 10,402 shares. During the past 18 months, 52,409 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 52,409 shares.

Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, David L. Lacey made no insider transaction in Unity Biotechnology Inc (UBX). Other recent insider transactions involving Unity Biotechnology Inc (UBX) include a net sale of 17,896 shares made by Anirvan Ghosh , and a net sale of 3,304 shares made by Jamie Dananberg .

In summary, during the past 3 months, insiders sold 603 shares of Unity Biotechnology Inc (UBX) in total and bought 0 shares, with a net sale of 603 shares. During the past 18 months, 21,200 shares of Unity Biotechnology Inc (UBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 21,200 shares.

Unity Biotechnology Inc (UBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, David L. Lacey made no insider transaction in Atreca Inc (BCEL). Other recent insider transactions involving Atreca Inc (BCEL) include a net sale of 34,668 shares made by Tito Serafini , a net sale of 11,137 shares made by Phillips Courtney , and a net sale of 274,739 shares made by Baker Bros. Advisors Lp .

In summary, during the past 3 months, insiders sold 20,788 shares of Atreca Inc (BCEL) in total and bought 0 shares, with a net sale of 20,788 shares. During the past 18 months, 353,058 shares of Atreca Inc (BCEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,058 shares.

Atreca Inc (BCEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, David L. Lacey made no insider transaction in Arcus Biosciences Inc (RCUS). Other recent insider transactions involving Arcus Biosciences Inc (RCUS) include a net sale of 223,626 shares made by Jennifer Jarrett , a net sale of 38,443 shares made by Juan C. Jaen , and a net sale of 8,506 shares made by Goeltz Ii Robert C. .

In summary, during the past 3 months, insiders sold 25,000 shares of Arcus Biosciences Inc (RCUS) in total and bought 0 shares, with a net sale of 25,000 shares. During the past 18 months, 286,423 shares of Arcus Biosciences Inc (RCUS) were sold and 16,248,095 shares were bought by its insiders, resulting in a net purchase of 15,961,672 shares.

Arcus Biosciences Inc (RCUS)'s detailed insider trading history can be found in Insider Trading Tracker table.